United States Biotechnology & Medical Research

Kite Pharma Inc (KITE)

Track

Track

Ticker: KITE Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
MOORE TIMOTHY L. EVP, Technical Operations
Transaction date
Sale
Price
436.49
Quantity 12,365 +23.4%
Value US$1,211,797
Wiezorek Jeffrey SVP Clinical Development
Transaction date
Sale
Price
403.47
Quantity 37,256 +14.0%
Value US$2,690,468
JENKINSON PAUL L Chief Financial Officer
Transaction date
Sale
Price
84.53
Quantity 8,562 +42.9%
Value US$2,966,991
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Sale
Price
179.66
Quantity 4,228 -3.4%
Value US$759,619
Belldegrun Arie Chairman, President and CEO Executive Director
Transaction date
Sale
Price
179.66
Quantity 26,347 -19.4%
Value US$4,733,605
Kim Helen Susan EVP, Business Development
Transaction date
Sale
Price
179.66
Quantity 3,171 -12.8%
Value US$569,714
Tomasello Shawn Chief Commercial Officer
Transaction date
Sale
Price
179.66
Quantity 4,203 -6.4%
Value US$755,127
Chang David D EVP, R&D, Chief Medical Off.
Transaction date
Sale
Price
179.66
Quantity 7,927 -12.1%
Value US$1,424,196
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
121.03
Quantity 5,800 -4.7%
Value US$701,974
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
120.52
Quantity 9,200 -6.9%
Value US$1,108,784
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
120.09
Quantity 6,251 -25.1%
Value US$750,683
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
121.37
Quantity 13,274 -41.6%
Value US$1,611,065
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
120.40
Quantity 31,165 -49.4%
Value US$3,752,266
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
119.94
Quantity 18,936 -23.1%
Value US$2,271,184
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
118.61
Quantity 3,800 -4.4%
Value US$450,718
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
117.27
Quantity 1,700 -1.9%
Value US$199,359
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
115.02
Quantity 11,074 -11.2%
Value US$1,273,731
MOORE TIMOTHY L. EVP, Technical Operations
Transaction date
Planned sale
Price
110.05
Quantity 5,131 -9.4%
Value US$564,667
MOORE TIMOTHY L. EVP, Technical Operations
Transaction date
Planned sale
Price
110.10
Quantity 869 -1.6%
Value US$95,677
MOORE TIMOTHY L. EVP, Technical Operations
Transaction date
Planned sale
Price
109.35
Quantity 321 -0.6%
Value US$35,101
MOORE TIMOTHY L. EVP, Technical Operations
Transaction date
Planned sale
Price
108.27
Quantity 3,771 -7.0%
Value US$408,286
MOORE TIMOTHY L. EVP, Technical Operations
Transaction date
Planned sale
Price
107.58
Quantity 5,431 -9.2%
Value US$584,267
MOORE TIMOTHY L. EVP, Technical Operations
Transaction date
Planned sale
Price
106.85
Quantity 2,477 -4.0%
Value US$264,667
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
111.60
Quantity 672 -3.5%
Value US$74,995
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
110.55
Quantity 2,725 -12.4%
Value US$301,249
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
109.74
Quantity 7,448 -25.2%
Value US$817,344
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
108.75
Quantity 15,804 -34.9%
Value US$1,718,685
BUTITTA CYNTHIA M Chief Operating Officer Officer
Transaction date
Planned sale
Price
105.50
Quantity 5,000 -4.1%
Value US$527,500
BUTITTA CYNTHIA M Chief Operating Officer Officer
Transaction date
Planned sale
Price
102.81
Quantity 1,100 -0.9%
Value US$113,091
BUTITTA CYNTHIA M Chief Operating Officer Officer
Transaction date
Planned sale
Price
102.19
Quantity 5,553 -4.3%
Value US$567,461
BUTITTA CYNTHIA M Chief Operating Officer Officer
Transaction date
Planned sale
Price
101.06
Quantity 3,347 -2.5%
Value US$338,248
Wiezorek Jeffrey SVP Clinical Development Officer
Transaction date
Planned sale
Price
104.76
Quantity 1,201 -5.4%
Value US$125,817
Wiezorek Jeffrey SVP Clinical Development Officer
Transaction date
Planned sale
Price
104.26
Quantity 8,799 -28.3%
Value US$917,384
WITTE OWEN N.
Transaction date
Sale
Price
100.60
Quantity 12,500 -14.1%
Value US$1,257,500
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
101.19
Quantity 2,050 -1.8%
Value US$207,440
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
100.54
Quantity 2,950 -2.5%
Value US$296,593
WITTE OWEN N.
Transaction date
Planned sale
Price
100.00
Quantity 12,500 -12.3%
Value US$1,250,000
CHAMPSI FARAH
Transaction date
Sale
Price
88.11
Quantity 5,450 -100.0%
Value US$480,200
CHAMPSI FARAH
Transaction date
Sale
Price
90.40
Quantity 15,000 -19.1%
Value US$1,356,000
Ruchefsky Steven B
Transaction date
Sale
Price
89.48
Quantity 20,000 -8.9%
Value US$1,789,574
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
91.08
Quantity 400 -0.3%
Value US$36,432
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
89.76
Quantity 1,698 -1.4%
Value US$152,412
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
89.09
Quantity 4,100 -3.3%
Value US$365,269
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
87.80
Quantity 2,502 -2.0%
Value US$219,676
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
86.42
Quantity 900 -0.7%
Value US$77,778
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
84.81
Quantity 400 -0.3%
Value US$33,924
DOUMANI ROY
Transaction date
Sale
Price
84.53
Quantity 5,000 -3.2%
Value US$422,634
DOUMANI ROY
Transaction date
Sale
Price
84.46
Quantity 10,000 -6.1%
Value US$844,621
Kim Helen Susan EVP, Business Development
Transaction date
Planned sale
Price
72.45
Quantity 2,400 -11.4%
Value US$173,880
JENKINSON PAUL L Chief Financial Officer Officer
Transaction date
Purchase
Price
72.59
Quantity 3,000 +inf%
Value US$217,770
JENKINSON PAUL L Chief Financial Officer Officer
Transaction date
Planned purchase
Price
72.57
Quantity 450 +6.4%
Value US$32,656
Nussbaum Ran Non-Executive Director
Transaction date
Purchase
Price
68.94
Quantity 2,632 +inf%
Value US$181,450
Nussbaum Ran Non-Executive Director
Transaction date
Purchase
Price
69.17
Quantity 1,029 +inf%
Value US$71,176
Nussbaum Ran Non-Executive Director
Transaction date
Purchase
Price
69.17
Quantity 2,651 +inf%
Value US$183,370
Nussbaum Ran Non-Executive Director
Transaction date
Purchase
Price
69.17
Quantity 3,520 +inf%
Value US$243,478
Ruchefsky Steven B Non-Executive Director
Transaction date
Purchase
Price
69.50
Quantity 1,400 +0.6%
Value US$97,300
Belldegrun Arie Chairman, President and CEO Executive Director
Transaction date
Purchase
Price
68.57
Quantity 17,000 +24.8%
Value US$1,165,690
BONDERMAN DAVID Non-Executive Director
Transaction date
Purchase
Price
70.15
Quantity 3,815 +0.2%
Value US$267,622
BONDERMAN DAVID Non-Executive Director
Transaction date
Purchase
Price
68.84
Quantity 46,185 +2.0%
Value US$3,179,375
Chang David D EVP, R&D, Chief Medical Off. Officer
Transaction date
Planned sale
Price
83.36
Quantity 300 -0.6%
Value US$25,008
Chang David D EVP, R&D, Chief Medical Off. Officer
Transaction date
Planned sale
Price
82.60
Quantity 5,905 -10.5%
Value US$487,753
Chang David D EVP, R&D, Chief Medical Off. Officer
Transaction date
Planned sale
Price
81.84
Quantity 13,795 -19.7%
Value US$1,128,983
Kim Helen Susan EVP, Business Development Officer
Transaction date
Planned sale
Price
82.12
Quantity 2,400 -11.4%
Value US$197,088
CHAMPSI FARAH Non-Executive Director
Transaction date
Sale
Price
82.59
Quantity 2,617 -34.5%
Value US$216,138
CHAMPSI FARAH Non-Executive Director
Transaction date
Sale
Price
82.77
Quantity 16,551 -68.6%
Value US$1,369,926
CHAMPSI FARAH
Transaction date
Sale
Price
83.06
Quantity 200 -0.8%
Value US$16,612
CHAMPSI FARAH
Transaction date
Sale
Price
82.72
Quantity 51,112 -67.8%
Value US$4,227,985
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
82.87
Quantity 3,742 -3.1%
Value US$310,100
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
82.14
Quantity 5,545 -4.4%
Value US$455,466
BUTITTA CYNTHIA M Chief Operating Officer
Transaction date
Planned sale
Price
80.89
Quantity 5,713 -4.3%
Value US$462,125
CHAMPSI FARAH
Transaction date
Sale
Price
83.29
Quantity 15,316 -16.9%
Value US$1,275,670
CHAMPSI FARAH
Transaction date
Sale
Price
82.56
Quantity 31,467 -25.7%
Value US$2,597,916
CHAMPSI FARAH
Transaction date
Sale
Price
82.34
Quantity 25,818 -17.4%
Value US$2,125,854
CHAMPSI FARAH
Transaction date
Sale
Price
83.06
Quantity 100 -0.1%
Value US$8,306
CHAMPSI FARAH
Transaction date
Sale
Price
82.48
Quantity 43,001 -22.5%
Value US$3,546,722
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-09-27 2017-09-25 S Sale MOORE TIMOTHY L.

EVP, Technical Operations
12,365 +23.4%
436.49
US$1,211,797 		12,365 +23.4% 436.49 US$1,211,797
2017-09-27 2017-09-25 S Sale Wiezorek Jeffrey

SVP Clinical Development
37,256 +14.0%
403.47
US$2,690,468 		37,256 +14.0% 403.47 US$2,690,468
2017-09-27 2017-09-25 S Sale JENKINSON PAUL L

Chief Financial Officer
8,562 +42.9%
84.53
US$2,966,991 		8,562 +42.9% 84.53 US$2,966,991
2017-09-27 2017-09-25 S Sale BUTITTA CYNTHIA M

Chief Operating Officer
4,228 -3.4%
179.66
US$759,619 		4,228 -3.4% 179.66 US$759,619
2017-09-27 2017-09-25 S Sale Belldegrun Arie

Chairman, President and CEO

Executive Director
26,347 -19.4%
179.66
US$4,733,605 		26,347 -19.4% 179.66 US$4,733,605
2017-09-27 2017-09-25 S Sale Kim Helen Susan

EVP, Business Development
3,171 -12.8%
179.66
US$569,714 		3,171 -12.8% 179.66 US$569,714
2017-09-27 2017-09-25 S Sale Tomasello Shawn

Chief Commercial Officer
4,203 -6.4%
179.66
US$755,127 		4,203 -6.4% 179.66 US$755,127
2017-09-27 2017-09-25 S Sale Chang David D

EVP, R&D, Chief Medical Off.
7,927 -12.1%
179.66
US$1,424,196 		7,927 -12.1% 179.66 US$1,424,196
2017-08-14 2017-08-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
5,800 -4.7%
121.03
US$701,974 		5,800 -4.7% 121.03 US$701,974
2017-08-14 2017-08-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
9,200 -6.9%
120.52
US$1,108,784 		9,200 -6.9% 120.52 US$1,108,784
2017-08-14 2017-08-10 PlS Planned sale Kim Helen Susan

EVP, Business Development
6,251 -25.1%
120.09
US$750,683 		6,251 -25.1% 120.09 US$750,683
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
13,274 -41.6%
121.37
US$1,611,065 		13,274 -41.6% 121.37 US$1,611,065
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
31,165 -49.4%
120.40
US$3,752,266 		31,165 -49.4% 120.40 US$3,752,266
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
18,936 -23.1%
119.94
US$2,271,184 		18,936 -23.1% 119.94 US$2,271,184
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
3,800 -4.4%
118.61
US$450,718 		3,800 -4.4% 118.61 US$450,718
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
1,700 -1.9%
117.27
US$199,359 		1,700 -1.9% 117.27 US$199,359
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
11,074 -11.2%
115.02
US$1,273,731 		11,074 -11.2% 115.02 US$1,273,731
2017-08-04 2017-08-03 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
5,131 -9.4%
110.05
US$564,667 		5,131 -9.4% 110.05 US$564,667
2017-08-04 2017-08-03 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
869 -1.6%
110.10
US$95,677 		869 -1.6% 110.10 US$95,677
2017-08-03 2017-08-01 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
321 -0.6%
109.35
US$35,101 		321 -0.6% 109.35 US$35,101
2017-08-03 2017-08-01 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
3,771 -7.0%
108.27
US$408,286 		3,771 -7.0% 108.27 US$408,286
2017-08-03 2017-08-01 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
5,431 -9.2%
107.58
US$584,267 		5,431 -9.2% 107.58 US$584,267
2017-08-03 2017-08-01 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
2,477 -4.0%
106.85
US$264,667 		2,477 -4.0% 106.85 US$264,667
2017-08-01 2017-07-31 PlS Planned sale Kim Helen Susan

EVP, Business Development
672 -3.5%
111.60
US$74,995 		672 -3.5% 111.60 US$74,995
2017-08-01 2017-07-31 PlS Planned sale Kim Helen Susan

EVP, Business Development
2,725 -12.4%
110.55
US$301,249 		2,725 -12.4% 110.55 US$301,249
2017-08-01 2017-07-31 PlS Planned sale Kim Helen Susan

EVP, Business Development
7,448 -25.2%
109.74
US$817,344 		7,448 -25.2% 109.74 US$817,344
2017-08-01 2017-07-31 PlS Planned sale Kim Helen Susan

EVP, Business Development
15,804 -34.9%
108.75
US$1,718,685 		15,804 -34.9% 108.75 US$1,718,685
2017-07-11 2017-07-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer

Officer
5,000 -4.1%
105.50
US$527,500 		5,000 -4.1% 105.50 US$527,500
2017-07-11 2017-07-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer

Officer
1,100 -0.9%
102.81
US$113,091 		1,100 -0.9% 102.81 US$113,091
2017-07-11 2017-07-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer

Officer
5,553 -4.3%
102.19
US$567,461 		5,553 -4.3% 102.19 US$567,461
2017-07-11 2017-07-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer

Officer
3,347 -2.5%
101.06
US$338,248 		3,347 -2.5% 101.06 US$338,248
2017-07-06 2017-07-03 PlS Planned sale Wiezorek Jeffrey

SVP Clinical Development

Officer
1,201 -5.4%
104.76
US$125,817 		1,201 -5.4% 104.76 US$125,817
2017-07-06 2017-07-03 PlS Planned sale Wiezorek Jeffrey

SVP Clinical Development

Officer
8,799 -28.3%
104.26
US$917,384 		8,799 -28.3% 104.26 US$917,384
2017-06-26 2017-06-26 S Sale WITTE OWEN N.
12,500 -14.1%
100.60
US$1,257,500 		12,500 -14.1% 100.60 US$1,257,500
2017-06-27 2017-06-23 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
2,050 -1.8%
101.19
US$207,440 		2,050 -1.8% 101.19 US$207,440
2017-06-27 2017-06-23 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
2,950 -2.5%
100.54
US$296,593 		2,950 -2.5% 100.54 US$296,593
2017-06-26 2017-06-23 PlS Planned sale WITTE OWEN N.
12,500 -12.3%
100.00
US$1,250,000 		12,500 -12.3% 100.00 US$1,250,000
2017-06-16 2017-06-16 S Sale CHAMPSI FARAH
5,450 -100.0%
88.11
US$480,200 		5,450 -100.0% 88.11 US$480,200
2017-06-16 2017-06-14 S Sale CHAMPSI FARAH
15,000 -19.1%
90.40
US$1,356,000 		15,000 -19.1% 90.40 US$1,356,000
2017-06-16 2017-06-14 S Sale Ruchefsky Steven B
20,000 -8.9%
89.48
US$1,789,574 		20,000 -8.9% 89.48 US$1,789,574
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
400 -0.3%
91.08
US$36,432 		400 -0.3% 91.08 US$36,432
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
1,698 -1.4%
89.76
US$152,412 		1,698 -1.4% 89.76 US$152,412
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
4,100 -3.3%
89.09
US$365,269 		4,100 -3.3% 89.09 US$365,269
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
2,502 -2.0%
87.80
US$219,676 		2,502 -2.0% 87.80 US$219,676
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
900 -0.7%
86.42
US$77,778 		900 -0.7% 86.42 US$77,778
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
400 -0.3%
84.81
US$33,924 		400 -0.3% 84.81 US$33,924
2017-06-09 2017-06-08 S Sale DOUMANI ROY
5,000 -3.2%
84.53
US$422,634 		5,000 -3.2% 84.53 US$422,634
2017-06-09 2017-06-07 S Sale DOUMANI ROY
10,000 -6.1%
84.46
US$844,621 		10,000 -6.1% 84.46 US$844,621
2017-06-05 2017-06-01 PlS Planned sale Kim Helen Susan

EVP, Business Development
2,400 -11.4%
72.45
US$173,880 		2,400 -11.4% 72.45 US$173,880
2017-05-10 2017-05-10 B Purchase JENKINSON PAUL L

Chief Financial Officer

Officer
3,000 +inf%
72.59
US$217,770 		3,000 +inf% 72.59 US$217,770
2017-05-10 2017-05-10 PP Planned purchase JENKINSON PAUL L

Chief Financial Officer

Officer
450 +6.4%
72.57
US$32,656 		450 +6.4% 72.57 US$32,656
2017-05-11 2017-05-09 B Purchase Nussbaum Ran Non-Executive Director
2,632 +inf%
68.94
US$181,450 		2,632 +inf% 68.94 US$181,450
2017-05-11 2017-05-09 B Purchase Nussbaum Ran Non-Executive Director
1,029 +inf%
69.17
US$71,176 		1,029 +inf% 69.17 US$71,176
2017-05-11 2017-05-09 B Purchase Nussbaum Ran Non-Executive Director
2,651 +inf%
69.17
US$183,370 		2,651 +inf% 69.17 US$183,370
2017-05-11 2017-05-09 B Purchase Nussbaum Ran Non-Executive Director
3,520 +inf%
69.17
US$243,478 		3,520 +inf% 69.17 US$243,478
2017-05-10 2017-05-09 B Purchase Ruchefsky Steven B Non-Executive Director
1,400 +0.6%
69.50
US$97,300 		1,400 +0.6% 69.50 US$97,300
2017-05-09 2017-05-09 B Purchase Belldegrun Arie

Chairman, President and CEO

Executive Director
17,000 +24.8%
68.57
US$1,165,690 		17,000 +24.8% 68.57 US$1,165,690
2017-05-09 2017-05-09 B Purchase BONDERMAN DAVID Non-Executive Director
3,815 +0.2%
70.15
US$267,622 		3,815 +0.2% 70.15 US$267,622
2017-05-09 2017-05-09 B Purchase BONDERMAN DAVID Non-Executive Director
46,185 +2.0%
68.84
US$3,179,375 		46,185 +2.0% 68.84 US$3,179,375
2017-05-03 2017-05-01 PlS Planned sale Chang David D

EVP, R&D, Chief Medical Off.

Officer
300 -0.6%
83.36
US$25,008 		300 -0.6% 83.36 US$25,008
2017-05-03 2017-05-01 PlS Planned sale Chang David D

EVP, R&D, Chief Medical Off.

Officer
5,905 -10.5%
82.60
US$487,753 		5,905 -10.5% 82.60 US$487,753
2017-05-03 2017-05-01 PlS Planned sale Chang David D

EVP, R&D, Chief Medical Off.

Officer
13,795 -19.7%
81.84
US$1,128,983 		13,795 -19.7% 81.84 US$1,128,983
2017-05-03 2017-05-01 PlS Planned sale Kim Helen Susan

EVP, Business Development

Officer
2,400 -11.4%
82.12
US$197,088 		2,400 -11.4% 82.12 US$197,088
2017-05-01 2017-04-28 S Sale CHAMPSI FARAH Non-Executive Director
2,617 -34.5%
82.59
US$216,138 		2,617 -34.5% 82.59 US$216,138
2017-05-01 2017-04-27 S Sale CHAMPSI FARAH Non-Executive Director
16,551 -68.6%
82.77
US$1,369,926 		16,551 -68.6% 82.77 US$1,369,926
2017-04-26 2017-04-26 S Sale CHAMPSI FARAH
200 -0.8%
83.06
US$16,612 		200 -0.8% 83.06 US$16,612
2017-04-26 2017-04-26 S Sale CHAMPSI FARAH
51,112 -67.8%
82.72
US$4,227,985 		51,112 -67.8% 82.72 US$4,227,985
2017-04-27 2017-04-25 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
3,742 -3.1%
82.87
US$310,100 		3,742 -3.1% 82.87 US$310,100
2017-04-27 2017-04-25 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
5,545 -4.4%
82.14
US$455,466 		5,545 -4.4% 82.14 US$455,466
2017-04-27 2017-04-25 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
5,713 -4.3%
80.89
US$462,125 		5,713 -4.3% 80.89 US$462,125
2017-04-26 2017-04-25 S Sale CHAMPSI FARAH
15,316 -16.9%
83.29
US$1,275,670 		15,316 -16.9% 83.29 US$1,275,670
2017-04-26 2017-04-25 S Sale CHAMPSI FARAH
31,467 -25.7%
82.56
US$2,597,916 		31,467 -25.7% 82.56 US$2,597,916
2017-04-26 2017-04-24 S Sale CHAMPSI FARAH
25,818 -17.4%
82.34
US$2,125,854 		25,818 -17.4% 82.34 US$2,125,854
2017-04-17 2017-04-17 S Sale CHAMPSI FARAH
100 -0.1%
83.06
US$8,306 		100 -0.1% 83.06 US$8,306
2017-04-17 2017-04-17 S Sale CHAMPSI FARAH
43,001 -22.5%
82.48
US$3,546,722 		43,001 -22.5% 82.48 US$3,546,722
Explore more

More insider trading research around Kite Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America